Research Identifies Predictors for Successful IVF

  Ferring Pharmaceuticals Reports Landmark Infertility Study Results at
         American Society for Reproductive Medicine Annual Meeting

   MONTREAL, Oct. 17 /PRNewswire/ -- Ferring Pharmaceuticals today presented
the results of a landmark clinical trial -- the largest in vitro fertilization
(IVF) trial powered on pregnancy rates ever undertaken in infertility.  Trial
results determined predictors for successful outcomes and were presented at
the 61st Annual Meeting of the American Society for Reproductive Medicine
(ASRM) in Montreal, Quebec, Canada, October 15 - 19, 2005.  A total of five
poster presentations and two oral presentations offered during the meeting
represented findings from this prospective, multicenter, multinational trial,
Menotropins versus Recombinant FSH In Vitro Fertilization Trial (MERiT).  A
total of 731 women underwent controlled ovarian hyperstimulation (COH)
following gonadotropin-releasing hormone (GnRH) agonist down-regulation in a
long treatment protocol.

read News at Research Identifies Predictors for Successful IVF